Bukwang Pharmaceutical announced on January 26 that it has improved the Braille printing method on its toothpaste packaging for the visually impaired.


Previously, on December 9 of last year, Oh Yu-kyung, Commissioner of the Ministry of Food and Drug Safety, visited Bukwang Pharmaceutical's headquarters to encourage the company for voluntarily adding Braille to its toothpaste products.

Sirinmedef Toothpaste Product. Bukwang Pharmaceutical

Sirinmedef Toothpaste Product. Bukwang Pharmaceutical

View original image

During this process, Bukwang Pharmaceutical reflected the results of discussions with the Ministry of Food and Drug Safety, the Korea Blind Union, and consumer organizations to improve the Braille printing method on its toothpaste packaging (Sirinmedef and Sirinmed Gum Care).


The company has shifted from the traditional embossing method (where the Braille is raised by pushing from the back) to a process that involves epoxy layering followed by UV (ultraviolet) curing. The embossing method can result in varying readability depending on the material, and the Braille may flatten over time or depending on storage conditions. However, the new method offers relatively higher readability and maintains the Braille height regardless of storage conditions or duration.


Bukwang Pharmaceutical explained, "We recently visited the Korea Blind Union and confirmed the effectiveness of the improvements after receiving an 'excellent' rating in the tactile test of the improved packaging."


Additionally, Bukwang Pharmaceutical has enhanced the QR code information on its toothpaste packaging. While the previous QR code linked to the company website, making it difficult to access intuitive product information, the improved QR code now directs users to the Drug Safety Korea product information page, allowing for more straightforward access. Bukwang Pharmaceutical added, "From the second half of this year, Drug Safety Korea plans to provide voice and sign language video content for these products, further enhancing accessibility for people with disabilities."


A Bukwang Pharmaceutical representative stated, "Among the toothpastes sold in the market, ours was the only one with Braille labeling, and the Commissioner of the Ministry of Food and Drug Safety recognized our efforts. Based on feedback from the Korea Blind Union, we further improved the Braille labeling. We are proud that this case demonstrates how active communication between the government and companies can enhance consumer rights."


The representative continued, "The Korea Institute of Drug Safety & Risk Management is proactively running a program to produce and provide voice and sign language videos tailored to individual products for companies that take the initiative in adding Braille. Through communication with the institute, Bukwang Pharmaceutical's toothpaste was selected for this program."


They added, "In the second half of this year, voice and sign language videos will be produced and provided. We will continue our efforts to improve accessibility for the visually impaired."



Meanwhile, Bukwang Pharmaceutical has previously produced YouTube content for the visually impaired. The content, titled 'AI-Read Over-the-Counter Drug Leaflet,' covers major products such as the fever reducer Tacehnol Cold Syrup (active ingredient: acetaminophen), the anemia treatment Feroba Premium Capsule (active ingredient: iron protein succinylate), and the health functional food Orem Biotin Eorin Collagen (active ingredient: low molecular fish collagen peptide).


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing